poisar

Stocks · News reference

CORRECTION: Pentair Q2 Adj. EPS $1.14 Misses $1.22 Estimate, Sales $932.600M Miss $958.064M Estimate

BenzingaBenzinga Newsdesk

Pentair (NYSE:PNR) reported quarterly earnings of $1.14 per share which missed the analyst consensus estimate of $1.22 by 6.56 percent. This is a 17.99 percent decrease over earnings of $1.39 per share from the same

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncKaplan Fox & Kilsheimer Llp

    Kaplan Fox Reminds Investors of a Securities Class Action Against UWM Holdings Corporation (NYSE: UWMC) – Deadline is October 13, 2026

    Kaplan Fox has filed securities class action lawsuits against UWM Holdings Corporation, Taboola.com Ltd., and Pentair plc on behalf of investors who suffered losses during specified periods. The primary case against UWM Holdings alleges the company failed to disclose that it had deviated from its traditional strategy by over-hedging mortgage servicing rights in anticipation of the Two Harbors transaction, resulting in a $603.2 million derivative loss and a 34.78% stock price decline on August 6, 2026.

  2. Globenewswire IncKaplan Fox & Kilsheimer Llp

    Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 for a Leadership Role

    Kaplan Fox & Kilsheimer LLP has filed class action lawsuits against Capricor Therapeutics, Pentair plc, and Bloom Energy Corporation on behalf of investors who suffered losses. The primary case involves Capricor, where the FDA released briefing documents revealing that the company made undisclosed changes to its statistical analysis plan for a drug application, resulting in a 64% stock price drop on July 27, 2026.